Security key
64130M209
NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock (NMTC)
CUSIP: 64130M209
Q1 2022 13F Holders as of 31 Mar 2022
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 8,477,622
- Total 13F shares
- 707,048
- Share change
- -1,239,077
- Total reported value
- $777,000
- Price per share
- $1.10
- Number of holders
- 8
- Value change
- -$2,285,922
- Number of buys
- 4
- Number of sells
- 8
Report period
Q1 2022
Institutions
8
Top holders
8
NMTC full security history
Newer quarter: Q2 2022
Previous quarter: Q4 2021
NEUROONE MEDICAL TECHNOLOGIES Corp SEC filings
NEUROONE MEDICAL TECHNOLOGIES Corp company facts
Broader feeds
Reporting periods
Holder history for CUSIP 64130M209
Recent filing periods:
Top shareholders of NMTC - NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| AWM Investment Company, Inc. |
13F
|
Company |
—
class O/S missing
|
1,414,172
|
$2,743,000 | — | 31 Dec 2021 | |
| Stonepine Capital Management, LLC |
13F
|
Company |
5.9%
|
498,354
|
$967,000 | — | 31 Dec 2021 | |
| AIGH Capital Management LLC |
13F
|
Company |
5.6%
|
475,000
|
$921,000 | — | 31 Dec 2021 | |
| Bleichroeder LP |
13F
|
Company |
4.4%
|
375,000
|
$728,000 | — | 31 Dec 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.6%
|
217,232
|
$421,000 | — | 31 Dec 2021 | |
| Worth Venture Partners, LLC |
13F
|
Company |
1.3%
|
108,964
|
$211,000 | — | 31 Dec 2021 | |
| Eidelman Virant Capital |
13F
|
Company |
0.88%
|
75,000
|
$146,000 | — | 31 Dec 2021 | |
| DRIVE WEALTH MANAGEMENT, LLC |
13F
|
Company |
0.79%
|
66,667
|
$129,000 | — | 31 Dec 2021 | |
| Intersect Capital LLC |
13F
|
Company |
0.59%
|
50,000
|
$97,000 | — | 31 Dec 2021 | |
| Aristides Capital LLC |
13F
|
Company |
0.43%
|
36,800
|
$71,000 | — | 31 Dec 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.18%
|
15,376
|
$30,000 | — | 31 Dec 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.18%
|
14,850
|
$29,000 | — | 31 Dec 2021 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.15%
|
12,882
|
$24,000 | — | 31 Dec 2021 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
258
|
$1,000 | — | 31 Dec 2021 |
Institutional Holders of NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock (NMTC) as of Q1 2022
As of 31 Mar 2022,
NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock (NMTC) was held by
8 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
707,048 shares.
The largest 8 holders included
Stonepine Capital Management, LLC, VANGUARD GROUP INC, DRIVE WEALTH MANAGEMENT, LLC, Intersect Capital LLC, GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Virtu Financial LLC, and NORTHERN TRUST CORP.
This page lists
8
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2022 vs Q4 2021 Across Filers
Q4 2021 holders
12
Q1 2022 holders
8
Holder diff
-4
| Investor | Q4 2021 Shares | Q1 2022 Shares | Share Diff | Share Chg % | Q4 2021 Value $ | Q1 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.